logo
  

Telefonica Deutschland Completes Acquisition Of KPN's E-Plus Group - Update

Telefonica SA's (TDE.L,TEF) Telefonica Deutschland has completed the acquisition of Dutch Telecom operator Royal KPN NV's (KPN,KKPNY.PK, KKPNF.PK) German mobile telecom business the E-Plus Group.

With the European Commission confirming clearance and the capital increase being successfully completed, the path is clear for the formation of the leading digital telecommunications company in Germany, the firm said.

With the closing of the transaction, the Management Board of the company
will consist of Thorsten Dirks as CEO, Markus Haas as COO and Rachel Empey as CFO.

It was on July 23, 2013, that Telefónica Deutschland agreed to acquire E-Plus from KPN. The deal was to see KPN receiving 3.7 billion euros in cash and an initial stake of 24.9 percent in Telefónica Deutschland.

The merger marks the beginning of one of the largest provider of telecommunication services in Germany with almost 47 million customer connections and a pro-forma revenue of around 7.9 billion euros in fiscal year 2013. The company is the number one in the market by mobile customers.

With the implementation of the acquisition, E-Plus will be a 100 percent
subsidiary of Telefonica Deutschland, and for the time being there will be no
changes for customers.

The design of the corporation as well as the concrete execution of the operative strategy will be decided in the next few months.

In the course of the transaction, the former owner of E-Plus, KPN, will
receive a cash disbursement as well as shares of the newly founded
Telefonica Deutschland Holding AG.

"The merger of our two companies provides us with the unique opportunity to act as a trend-setter and create real added value for our company and
customers," said Thorsten Dirks, CEO of Telefonica Deutschland Holding.

Telefonica SA closed up 1.1 percent in Madrid on Tuesday at 12.26 euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
RELATED NEWS
Follow RTT